Abstract:Objective: To explore the predictive effect of the renal tumor scoring system on the surgical outcomes of cystic renal masses (CRM). Methods: A retrospective analysis was performed on the data of 234 patients who received robotic-assisted partial nephrectomy (RAPN) treatment in the First Affiliated Hospital of Xi'an Jiaotong University from January 2018 to June 2020. And 31 cases had CRM and 203 cases had solid renal masses (SRM). The propensity score of patients was calculated by logistic regression model, and 1∶2 matching was performed by the nearest neighbor method. The changes in perioperative indexes and long-term estimated glomerular filtration rate (eGFR) in CRM group and SRM group were compared. The CRM group and SRM group were stratified according to the complexity grading of R.E.N.A.L. score and PADUA score, respectively, to compare the difference in the achievement rate of ideal surgical outcome between the two groups, and analyze the predictive factors affected. The CRM diameter was stratified with 4 cm as the cut-off value (CRM1 group with a diameter<4 cm, CRM2 group with a diameter≥4 cm), and the surgical results were compared with the matched SRM1 group and SRM2 group. Results: In the matching cohort, the CRM group comprised 29 patients with a mean age of (48.7±10.8) years, of which 22 (75.9%) were males. The SRM group included 58 patients with a mean age of (50.4±10.2) years, of which 41 (70.7%) were males, with no statistically significant difference (all P>0.05). The warm ischemia time (WIT) [M (Q1,Q3)] in the CRM group was longer than that in the SRM group [23(18, 25) vs 19(17, 25) min, P=0.040]. The operation time (OT) [M (Q1,Q3)] in the CRM group was also longer than that of the SRM group [130(100, 150) vs 108(86, 120) min, P=0.006]. The change in serum creatinine before and after the operation [M (Q1,Q3)] was higher in the CRM group than in the SRM group [15(10, 23) vs 12(6, 17) μmol/L, P=0.030]. The ideal surgical outcomes were achieved in 7 patients (24.1%) in the CRM group and 36 patients (62.1%) in the SRM group. The number of patients achieving ideal surgical outcomes in R.E.N.A.L. intermediate complex surgery and PADUA advanced complex surgery in the SRM group were 24 (58.5%) and 15 (51.7%), respectively, which were higher than those in the CRM group 6 (27.3%) and 1 (5.9%) respectively (P<0.05). Preoperative eGFR (OR=0.758, 95%CI: 0.719-0.799) and the nature of the tumor (CRM as reference, OR=4.883, 95%CI: 1.550-15.378) were influencing factors for achieving the ideal surgical outcome. Subgroup analysis showed that eGFR changes before and after surgery and the estimated blood loss (EBL) in the CRM2 group were higher than those in the SRM2 group, and WIT and OT were longer than those in the SRM2 group (all P<0.05). The EBL and WIT of the CRM1 group were shorter than those of the CRM2 group (P<0.05). Conclusion: The surgical risk of RAPN in complex CRMs with a maximum diameter of≥4 cm is higher than the risk of RAPN in SRM with equivalent R.E.N.A.L. and PADUA scores.

Multilocular Cystic Renal Cell Carcinoma:Comparison the Safety and Efficacy of Three Different Operations.

A Clinical Analysis of Multilocular Cystic Renal Cell Carcinoma and Its Correlation with Mutation of the Von Hippel-Lindau Gene

[A Rational Analysis of the Commonly Used Renal Tumor Scoring Systems in Predicting Surgical Outcomes of Cystic Renal Masses].

Laparoscopic Versus Open Partial Nephrectomy for Multilocular Cystic Renal Cell Carcinoma: a Direct Comparison Based on Single-Center Experience.

Retroperitoneal laparoscopic nephron-sparing surgery for renal tumor:report of 15 cases

Diagnosis and Treatment of Multilocular Cystic Renal Cell Carcinoma:A Study of 22 Cases

Clinical and pathological analysis of multilocular cystic renal cell carcinoma

Diagnosis and treatment of multilocular cystic renal cell carcinoma

Laparoscopic partial nephrectomy for multilocular cystic renal cell carcinoma: a potential gold standard treatment with excellent perioperative outcomes

Prognosis of Surgery in Multilocular Cystic Renal Cell Carcinoma (report of 22 Cases)

Multilocular cystic renal cell carcinoma: an experience of clinical management for 31 cases

Tumor Enucleation Vs. Partial Nephrectomy for T1 Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

[A Retrospective Study Comparing the Clinical Efficacy of Laparoscopic Cryoablation and Partial Nephrectomy for Renal Cell Carcinoma].

Evaluation of Nephron-Sparing Surgery for Renal Cell Carcinoma

[Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential].

Clinicopathological characteristics and typing of multilocular cystic renal neoplasm of low malignant potential

Analysis of different surgical treatments of retroperitoneal laparoscopic partial nephrectomy for patients with localized renal cell carcinoma

Clinical study of laporoscopic nephron sparing surgery for T1 renal cell carcinoma

Comparison of Clinical Efficacy in the Treatment of Renal Cell Carcinoma: Laparoscopic Cool-Tip Radiofrequency Ablation Vs Partial Nephrectomy

Comparison of different surgical treatment of retroperitoneal laparoscopic partial nephrectomy for patients with localized renal cell carcinoma

Multilocular Cystic Renal Cell Neoplasm of Low Malignant Potential: A Series of 76 Cases.